17 July 2007 in Proceedings of the National Academy of Sciences
Nanostructured biomaterials have tremendous potential for tissue engineering. However, the performance and integration of the nanomaterials in vivo are not well understood. A challenge in vascular tissue engineering is to develop optimal scaffolds and establish expandable cell sources for the construction of tissue-engineered vascular grafts that are nonthrombogenic and have long-term patency. Here, we used tissue-engineered vascular grafts as a model to demonstrate the potential of combining nanofibrous scaffolds and bone marrow mesenchymal stem cells (MSCs) for vascular tissue engineering. Biodegradable nanofibrous scaffolds with aligned nanofibers were used to mimic native collagen fibrils to guide cell organization in vascular grafts. The results from artery bypass experiments showed that nanofibrous scaffolds allowed efficient infiltration of vascular cells and matrix remodeling. Acellular grafts (without MSCs) resulted in significant intimal thickening, whereas cellular grafts (with MSCs) had excellent long-term patency and exhibited well organized layers of endothelial cells (ECs) and smooth muscle cells (SMCs), as in native arteries. Short-term experiments showed that nanofibrous scaffolds alone induced platelet adhesion and thrombus formation, which was suppressed by MSC seeding. In addition, MSCs, as ECs, resisted platelet adhesion in vitro , which depended on cell-surface heparan sulfate proteoglycans. These data, together with the observation on the short-term engraftment of MSCs, suggest that the long-term patency of cellular grafts may be attributed to the antithrombogenic property of MSCs. These results demonstrate several favorable characteristics of nanofibrous scaffolds, the excellent patency of small-diameter nanofibrous vascular grafts, and the unique antithrombogenic property of MSCs.
1 March 2021 in Advanced Drug Delivery Reviews
Fibronectin structure and composition regulate contextual cell signaling. Recent advances have been made in understanding fibronectin and its role in tissue organization and repair. This review outlines fibronectin splice variants and their functions, evaluates potential therapeutic strategies targeting or utilizing fibronectin, and concludes by discussing potential future directions to modulate fibronectin function in development and wound healing.
19 August 2015 in Science Translational Medicine
RERoberto C. Andresen Eguiluz
Roberto C. Andresen Eguiluz
+12
Obesity leads to fibrotic remodeling of mammary adipose tissue, and the resulting increase in interstitial extracellular matrix stiffness promotes breast tumor malignancy.
19 January 2023 in Lab on a Chip
Representation of the influence of biological and nanoscale factors on protein corona conformation and function in a healthy versus a pathogenic biological environment.
8 May 2020 in Proceedings of the National Academy of Sciences
Significance: Pathologic fibrosis is associated with altered collagen microarchitecture, but the functional impact of these changes on myofibroblast differentiation remains poorly understood. We experimentally and computationally analyzed the effect of collagen microstructure on matrix mechanics and determined its functional consequences on adipose-derived stem cells (ASCs), a cell type contributing to obesity- and cancer-associated fibrosis. Our findings highlight that collagen networks with thicker fibers and larger pores exhibit higher shear moduli than their similarly concentrated counterparts with thinner fibers and smaller pores. These differences promoted ASC mechanosignaling and consequential differentiation into α-smooth muscle actin-positive, contractile, and proangiogenic myofibroblasts. Insights from this work will advance the design of biomaterials for tissue engineering applications as well as antifibrotic therapies.
26 May 2022 in Journal of the American Chemical Society